Skip to main content

Table 3. Change in functional status in study groups at 6 months.

FCM group (n = 35) Non-FCM group (n = 30)
Baseline 6-month follow-up p value Baseline 6-month follow-up p value
NYHA Class II 43% (15/35) 91% (32/35) < 0.0001 63% (19/30) 60% (18/30) 1.000
NYHA Class III 57% (20/35) 9% (3/35) 37% (11/30) 40% (12/30)

Results reported as % (n/N).

FCM, ferric carboxymaltose; NYHA, New York Heart Association.